GlassScriptPhysician profile
Travis D Farmer
NPI 1346564234
$17,395.95
in general payments reported to CMS, 2019-2025
12 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,042 · 2020: $10K · 2021: $2,834 · 2022: $135 · 2023: $199 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,412.00 | 2020-2021 | |
| Medinc of Texas | $2,537.00 | 2019 | |
| Team 1, LLC | $1,200.00 | 2021 | |
| Axogen | $958.75 | 2019-2025 | |
| Stryker Corporation | $484.27 | 2019-2021 | |
| Smith+Nephew, INC. | $292.68 | 2022-2023 | Evos, Trigen Intertan |
| Skeletal Dynamics INC | $197.99 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $150.90 | 2019-2020 | |
| Acumed LLC | $97.46 | 2019 | |
| Integra Lifesciences Corporation | $23.97 | 2022 | |
| Arthrosurface Incorporated | $23.52 | 2020 | |
| Dynasplint Systems INC. | $17.41 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.